Transitioning Electronic Support for Public Health (ESP) from Lab to Marketplace

将公共卫生电子支持 (ESP) 从实验室转变为市场

基本信息

  • 批准号:
    8919742
  • 负责人:
  • 金额:
    $ 33.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-01 至 2016-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Accurate and complete disease surveillance is critical to enable public health authorities to detect and respond to disease outbreaks, epidemics, and even bioterrorism events. While legally required of healthcare practitioners and practices, most notifiable disease reporting is still done manually or through limited automated laboratory test result reporting. This creates a substantial burden on practitioners and produces sparse data that does not meet the full requirements of the agencies responsible for protecting public health. To address limitations in reporting and surveillance, the Centers for Disease Control and Prevention, beginning in 2005, sponsored a project to develop and pilot an open-source electronic system (called EHR Support for Public Health, or ESP) to automate the detection and reporting of notifiable diseases by taking advantage of the rich information coded into electronic health record (EHR) systems. Collaborating institutions included Harvard Medical School, Harvard Vanguard Medical Associates, and the Massachusetts Department of Public Health. CDC and AHRQ subsequently funded the creation of additional prototypes for syndromic surveillance, chronic disease prevalence monitoring, and automated detection and reporting of vaccine adverse events, as well as the fielding of ESP as a vehicle for enhanced surveillance of sexually transmitted diseases. We believe that ESP is a near-perfect basis for the NIH's Lab to Marketplace (Tools for Biomedical and Behavioral Research) SBIR solicitation. It represents advanced, proven-to-be-useful technology that was developed with substantial DHHS investment, but it is only in use so far at a handful of institutions. There is a real danger that ESP will never attain "lift-off" as a sustained, viable commercial activity. The overall goalsof this project are to realize the full functional potential of ESP, to make it more robust and easier to use and deploy, and to take the necessary steps to move it onto a pathway to wider deployment. Specifically, the project will take advantage of emerging healthcare data standards to increase portability of ESP across EHR systems and to reduce the maintenance and management burden on healthcare practices for the setup and use of ESP and for access to the data captured by the system. As an enabling component for enhancing disease detection, the project also includes the development of an automated processing module for free-text laboratory microbiology reports. Utilizing this foundation, the project will significantly extend te set of diseases detected within ESP and complete the existing prototype ESP capabilities mentioned above. The project involves close collaboration with experts at the organization (the Harvard Department of Population Medicine) that led the original development work on ESP as well as with the MetroHealth System of Northeast Ohio, a regional healthcare provider that has been running ESP on a production basis since 2009.
描述(由申请人提供):准确而完整的疾病监测对于使公共卫生当局能够检测和应对疾病暴发,流行病甚至生物恐怖事件至关重要。虽然法律上需要医疗保健从业者和实践,但大多数明显的疾病报告仍是手动或通过有限的自动实验室测试结果报告进行的。这给从业人员带来了重大负担,并产生了稀疏的数据,这些数据不符合负责保护公共卫生的机构的全部要求。为了解决报告和监视的局限性,从2005年开始,疾病控制和预防中心赞助了一个项目,以开发和试行一个开源电子系统(称为EHR对公共卫生或ESP的EHR支持),以自动化可检测和报告可识别的疾病,以利用丰富的信息来编码电子健康记录(EHR)系统。合作机构包括哈佛医学院,哈佛先锋医疗伙伴和马萨诸塞州公共卫生部。 CDC和AHRQ随后资助了为综合症监测,慢性疾病患病率监测以及疫苗不良事件的自动检测和报告的创建其他原型,以及将ESP作为野外野外疾病的载体,以增强性传播疾病的监测。我们认为,ESP是NIH实验室到市场的近乎完美的基础(生物医学和行为研究工具)SBIR招标。它代表了通过大量DHHS投资开发的先进,可使用的技术,但仅在少数机构中才使用。 ESP永远不会成为一种持续,可行的商业活动,这是一种真正的危险。该项目的总体目标是实现ESP的全部功能潜力,以使其更加健壮,更容易 使用和部署,并采取必要的步骤将其移至更广泛部署的途径。具体而言,该项目将利用新兴的医疗保健数据标准,以增加ESP跨EHR系统的可移植性,并减少用于设置和使用ESP以及访问系统捕获的数据的医疗保健实践的维护和管理负担。作为增强疾病检测的促成组成部分,该项目还包括开发自由文本实验室微生物学报告的自动加工模块。利用该基础,该项目将大大扩展ESP中检测到的一组疾病,并完成上面提到的现有原型ESP功能。该项目涉及与该组织(哈佛人口医学系)的专家密切合作,该组织领导了ESP的原始开发工作以及俄亥俄州东北部的Metrohealth System,这是自2009年以来一直在生产基础上运行ESP的区域医疗保健提供商。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID M FRAM其他文献

DAVID M FRAM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID M FRAM', 18)}}的其他基金

Transitioning Electronic Support for Public Health (ESP) from Lab to Marketplace
将公共卫生电子支持 (ESP) 从实验室转变为市场
  • 批准号:
    8781524
  • 财政年份:
    2014
  • 资助金额:
    $ 33.38万
  • 项目类别:
Safety Data Mining Based on Chemical Structures
基于化学结构的安全数据挖掘
  • 批准号:
    6865093
  • 财政年份:
    2005
  • 资助金额:
    $ 33.38万
  • 项目类别:
Discriminating Drug Safety Profiles in Polytherapy
综合治疗中药物安全性的区别
  • 批准号:
    6738316
  • 财政年份:
    2004
  • 资助金额:
    $ 33.38万
  • 项目类别:
Next-Generation Safety Data Mining System
下一代安全数据挖掘系统
  • 批准号:
    6549272
  • 财政年份:
    2002
  • 资助金额:
    $ 33.38万
  • 项目类别:
Next-Generation Safety Data Mining System
下一代安全数据挖掘系统
  • 批准号:
    6712111
  • 财政年份:
    2002
  • 资助金额:
    $ 33.38万
  • 项目类别:
Next-Generation Safety Data Mining System
下一代安全数据挖掘系统
  • 批准号:
    6684442
  • 财政年份:
    2002
  • 资助金额:
    $ 33.38万
  • 项目类别:
META-ANALYSIS OF DRUG ABUSE TREATMENT OUTCOME STUDIES
药物滥用治疗结果研究的荟萃分析
  • 批准号:
    3635541
  • 财政年份:
    1995
  • 资助金额:
    $ 33.38万
  • 项目类别:
META-ANALYSIS OF DRUG ABUSE TREATMENT OUTCOME STUDIES
药物滥用治疗结果研究的荟萃分析
  • 批准号:
    3635542
  • 财政年份:
    1995
  • 资助金额:
    $ 33.38万
  • 项目类别:
GENOMIC SEQUENCE SEARCH SOFTWARE FOR PROPHET II
Prophet II 的基因组序列搜索软件
  • 批准号:
    2326186
  • 财政年份:
    1994
  • 资助金额:
    $ 33.38万
  • 项目类别:
SEQUENCE DATA VISUALIZATION SOFTWARE FOR PROPHET
Prophet 的序列数据可视化软件
  • 批准号:
    2326134
  • 财政年份:
    1993
  • 资助金额:
    $ 33.38万
  • 项目类别:

相似海外基金

Establishment of a Bat Resource for Infectious Disease Research
建立用于传染病研究的蝙蝠资源
  • 批准号:
    10495114
  • 财政年份:
    2023
  • 资助金额:
    $ 33.38万
  • 项目类别:
Development of antibody drug conjugates as pan-filo antivirals
开发作为泛型抗病毒药物的抗体药物偶联物
  • 批准号:
    10759731
  • 财政年份:
    2023
  • 资助金额:
    $ 33.38万
  • 项目类别:
A comparative evaluation of overdose prevention programs in New York City and Rhode Island
纽约市和罗德岛州药物过量预防计划的比较评估
  • 批准号:
    10629749
  • 财政年份:
    2023
  • 资助金额:
    $ 33.38万
  • 项目类别:
Intracellular functions and mechanisms of alphavirus ion channel 6K
甲病毒离子通道6K的细胞内功能和机制
  • 批准号:
    10727819
  • 财政年份:
    2023
  • 资助金额:
    $ 33.38万
  • 项目类别:
Point-of-care diagnostic test for T. cruzi (Chagas) infection
克氏锥虫(恰加斯)感染的即时诊断测试
  • 批准号:
    10603665
  • 财政年份:
    2023
  • 资助金额:
    $ 33.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了